We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Udg Healthcare Public Limited Company | LSE:UDG | London | Ordinary Share | IE0033024807 | ORD EUR0.05 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,079.00 | 1,078.00 | 1,079.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMUDG
U.K. DISCLOSURE, Aug. 16, 2021 (GLOBE NEWSWIRE) --
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION Name of person dealing (Note 1) Glazer Capital, LLC -------------------------------------------------------- -------------------- Company dealt in UDG Healthcare plc -------------------------------------------------------- -------------------- Class of relevant security to which the dealings being EUR0.05 ordinary disclosed relate (Note 2) shares -------------------------------------------------------- -------------------- Date of dealing August 13, 2021 -------------------------------------------------------- -------------------- 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short ----------------------------------- ---------------------- ------------- Number (%) Number (%) ----------------------------------- --------------- ----- -------- --- (1) Relevant securities 0 (0%) 0 (0%) ----------------------------------- ---------------------- ------------- (2) Derivatives (other than options) 13,304,375 (5.28%) 0 (0%) ----------------------------------- ---------------------- ------------- (3) Options and agreements to purchase/sell 0 (0%) 0 (0%) ----------------------------------- ---------------------- ------------- Total 13,304,375 (5.28%) 0 (0%) ----------------------------------- ---------------------- ------------- (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short ---------------------------------------------- --------------- --------------- Number (%) Number (%) ---------------------------------------------- -------- --- -------- --- (1) Relevant securities ---------------------------------------------- --------------- --------------- (2) Derivatives (other than options) ---------------------------------------------- --------------- --------------- (3) Options and agreements to purchase/sell ---------------------------------------------- --------------- --------------- Total ---------------------------------------------- --------------- ---------------
Ap20
1. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of relevant securities Price per unit (Note 5) ---------------- -------------------------------- -------------------------- (b) Derivatives transactions (other than options transactions) Product name, Nature of transaction Number of relevant securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) --------------- ----------------------- ------------------------------- ---------------- CFD Decreased Long 1,508,838 10.79 GBP --------------- ----------------------- ------------------------------- ---------------- (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of securities to which the option relates (Note Exercise Type, Expiry Option money e.g. call option selling, 7) price e.g. date paid/received purchasing, American, per unit varying European (Note 5) etc. etc. ------------------- ------------- -------------------------------------------------------- ---------- ----------- -------- --------------- (ii) Exercising Product name, Number of securities Exercise price per unit (Note e.g. call option 5) ------------------- ---------------------- --------------------------------- (d) Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) ----------------------- --------- ---------------------------
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. ------------------------------------------------------------- None -------------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) YES/NO
Date of disclosure August 16, 2021 --------------------------------------------------------- ----------------- Contact name Megan Boylan --------------------------------------------------------- ----------------- Telephone number (212) 808-7302 --------------------------------------------------------- ----------------- If a connected EFM, name of offeree/offeror with which connected --------------------------------------------------------- ----------------- If a connected EFM, state nature of connection (Note 10) --------------------------------------------------------- -----------------
(END) Dow Jones Newswires
August 16, 2021 10:30 ET (14:30 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Udg Healthcare Public Chart |
1 Month Udg Healthcare Public Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions